Elevance Health Inc. ANTM
482.58 0.00 (+0.00%)
At closeJun 28, 2022, 12:00 AM EDT
466.74 Day range 485.75
52-week range unavailable
Analyst view
Consensus: buy
Buy
Price target (mean) 565.23 +17.1% upside
Now 482.58
- Target (low)
- 335.00
- Target (mean)
- 565.23
- Target (high)
- 642.00
Ratings (0m) 19 11 buy · 8 hold · 0 sell
- Strong buy7
- Buy4
- Hold8
- Sell0
- Strong sell0
Recommendation trend
- This month 19
- 1 month ago 24
- 2 months ago 24
- 3 months ago 25
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 7.73 | 7.38 – 7.92 | 7.03 | +10.0% | 38.15B | +14.6% | 20 |
| Next quarter | 7.11 | 6.44 – 7.90 | 6.79 | +4.7% | 38.84B | 0.0% | 20 |
| Current year | 28.64 | 28.46 – 29.30 | 25.98 | +10.2% | 153.78B | +12.3% | 24 |
| Next year | 32.47 | 31.98 – 33.25 | 28.64 | +13.4% | 161.69B | +5.1% | 24 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 22, 2022 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jun 17, 2022 | Loop Capital | Initiated | — | Buy |
| May 25, 2022 | Wells Fargo | Maintained | — | Overweight |
| Apr 25, 2022 | BMO Capital | Maintained | — | Outperform |
| Apr 22, 2022 | Deutsche Bank | Maintained | — | Buy |
| Apr 21, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Apr 21, 2022 | Credit Suisse | Maintained | — | Outperform |
| Apr 21, 2022 | Goldman Sachs | Maintained | — | Buy |
| Apr 21, 2022 | SVB Leerink | Maintained | — | Market Perform |
| Mar 29, 2022 | UBS | Maintained | — | Buy |
| Mar 15, 2022 | SVB Leerink | Maintained | — | Market Perform |
| Feb 7, 2022 | Argus Research | Maintained | — | Buy |
| Jan 28, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Jan 27, 2022 | SVB Leerink | Maintained | — | Market Perform |
| Jan 3, 2022 | RBC Capital | Maintained | — | Sector Perform |
| Dec 20, 2021 | Mizuho | Upgrade | Neutral | Buy |
| Dec 17, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Oct 29, 2021 | Mizuho | Maintained | — | Neutral |
| Oct 25, 2021 | Wells Fargo | Maintained | — | Overweight |
| Oct 21, 2021 | Stephens & Co. | Maintained | — | Overweight |
| Oct 21, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Oct 21, 2021 | Barclays | Maintained | — | Overweight |
| Oct 21, 2021 | RBC Capital | Maintained | — | Sector Perform |
| Oct 21, 2021 | Credit Suisse | Maintained | — | Outperform |
| Oct 21, 2021 | SVB Leerink | Maintained | — | Market Perform |
| Sep 27, 2021 | SVB Leerink | Initiated | — | Market Perform |
| Aug 31, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Jul 22, 2021 | Mizuho | Maintained | — | Neutral |
| Jul 22, 2021 | Jefferies | Maintained | — | Buy |
| Jul 22, 2021 | Stephens & Co. | Maintained | — | Overweight |